Tested Applications
| Positive WB detected in | HEK-293 cells, RAW264.7, HeLa cells, HepG2 cells, NIH/3T3 cells |
| Positive IHC detected in | human kidney tissue, human testis tissue, human brain tissue, human lung tissue, human ovary tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15548-1-AP targets NADK in WB, IHC, IF/ICC, CoIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag7906 Product name: Recombinant human NADK protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 98-446 aa of BC001709 Sequence: LTWNKSPKSVLVIKKMRDASLLQPFKELCTHLMEENMIVYVEKKVLEDPAIASDESFGAVKKKFCTFREDYDDISNQIDFIICLGGDGTLLYASSLFQGSVPPVMAFHLGSLGFLTPFSFENFQSQVTQVIEGNAAVVLRSRLKVRVVKELRGKKTAVHNGLGEKGSQAAGLDMDVGKQAMQYQVLNEVVIDRGPSSYLSNVDVYLDGHLITTVQGDGVIVSTPTGSTAYAAAAGASMIHPNVPAIMITPICPHSLSFRPIVVPAGVELKIMLSPEARNTAWVSFDGRKRQEIRHGDSISITTSCYPLPSICVRDPVSDWFESLAQCLHWNVRKKQAHFEEEEEEEEEG Predict reactive species |
| Full Name | NAD kinase |
| Calculated Molecular Weight | 49 kDa |
| Observed Molecular Weight | 49 kDa |
| GenBank Accession Number | BC001709 |
| Gene Symbol | NADK |
| Gene ID (NCBI) | 65220 |
| RRID | AB_2147345 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O95544 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
NAD kinase (NADK) is the sole NADP+-biosynthetic enzyme that catalyzes phosphorylation of NAD+ to yield NADP+ using ATP as a phosphoryl donor, and thus, plays a vital role in the cell and represents a potentially powerful antimicrobial drug target (PMID:21526340). It belongs to the NAD kinase family. NADK has 3 isoforms with the molecular mass of 49, 63 and 46 kDa. The catalytically active human NADK is a homotetramer (PMID:11594753).
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for NADK antibody 15548-1-AP | Download protocol |
| IHC protocol for NADK antibody 15548-1-AP | Download protocol |
| WB protocol for NADK antibody 15548-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The NADK Polyclonal antibody (15548-1-AP) has a total of 13 citations across journals including Cell Metabolism, Nature Communications, Redox Biology, Nucleic Acids Research, Science Advances, International Journal of Biological Sciences, Oncogenesis, ACS Omega, FASEB Journal, Journal of Biological Chemistry, Journal of Cancer Research and Clinical Oncology, Technology in Cancer Research & Treatment, and Clinical and Experimental Hepatology.
The research fields focus primarily on cancer biology (breast cancer metastasis, NSCLC, gastric cancer, lung adenocarcinoma, colorectal cancer), metabolism (NADP(H) synthesis, pentose phosphate pathway, redox/antioxidant defense, ferroptosis), DNA damage response, and molecular markers in disease (glaucoma, liver cirrhosis).
| Species | Application | Title |
|---|---|---|
Cell Metab Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation.
| ||
Nat Commun NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression. | ||
Redox Biol NADK-mediated de novo NADP(H) synthesis is a metabolic adaptation essential for breast cancer metastasis | ||
Nucleic Acids Res Human DNA ligase IV is able to use NAD+ as an alternative adenylation donor for DNA ends ligation. | ||
Sci Adv G6PD-mediated increase in de novo NADP+ biosynthesis promotes antioxidant defense and tumor metastasis. | ||
Int J Biol Sci Nicotinamide adenine dinucleotide kinase promotes lymph node metastasis of NSCLC via activating ID1 expression through BMP pathway
|

























